Diagnosticos da America company profile
Company profile
Diagnosticos da America has 26,255 employees and is headquartered in São Paulo, Brazil.
Clinical diagnostics, hospital care and oncology services in Brazil and Argentina form the core of Diagnósticos da América S.A., which was founded in 1961 and was formerly known as Laboratório Clínico Delboni Auriemo S.A. until it changed its name in August 2000. The company reports through three segments: hospitals and oncology, national diagnostics operations in Brazil, and international diagnostics operations. Its offering also includes medical services, property and vehicle rental, consultancy and franchise contracting.
In the fiscal year ended December 2025, the group, including its subsidiaries, reported revenue of BRL 11.2 billion, down 27.1% from the previous year, and a net loss of BRL 1.2 billion. The company employed 26,255 people. Its headquarters are in São Paulo, Brazil.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Brazil
- Headquarters
- Av. das Nações Unidas, 7815, 05425-070, São Paulo
- Employees
- 26,255
- Chief executive
- Rafael Lucchesi
- Founded
- 1961
- Fiscal year
- January - December
- Listing
- DASA3 · B3
- Currency
- BRL
- ISIN
- BRDASAACNOR1
- Website
- dasa3.com.br
Diagnosticos da America and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Diagnosticos da AmericaDASA3 | Brazil | $686.17M | 26,255 | 10.9% | — |
| FleuryFLRY3 | Brazil | $1.97B | 32,000 | 16.0% | 15.0 |
| DiagnostykaDIA | Poland | $1.27B | 8,645 | 14.9% | 20.2 |
| DiaSorinDIA | Italy | $4.21B | 3,212 | 22.3% | 28.6 |
| Sonic HealthcareSHL | Australia | $7.13B | 47,000 | 9.3% | 17.6 |
| WuXi XDC Cayman2268 | Hong Kong SAR China | $9.64B | 3,628 | 28.1% | 46.6 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
